Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
13.9M
-
Shares change
-
+697K
-
Total reported value, excl. options
-
$398M
-
Value change
-
+$23.8M
-
Number of buys
-
37
-
Number of sells
-
-21
-
Price
-
$28.62
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2019
73 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2019.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.9M shares
of 50M outstanding shares and own 27.81% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (1.83M shares), RA CAPITAL MANAGEMENT, LLC (1.44M shares), Vivo Capital, LLC (1.36M shares), Polar Capital LLP (1.15M shares), VHCP Management III, LLC (971K shares), EVENTIDE ASSET MANAGEMENT, LLC (900K shares), FMR LLC (735K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (665K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (650K shares), and VHCP Management II, LLC (573K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.